Oxy Watchdog

Keeping An Eye On OxyContin

Posts Tagged ‘Schedule II narcotics’

New brand of prescription painkiller oxycodone approved

Posted by Oxy Watchdog on October 23, 2010

A new form of oxycodone hydrochloride, a synthetic opiate like the brand name drug OxyContin, was approved by the U.S. Food and Drug Administration this week, reports this release from the FDA. Lehigh Valley Technologies formulated the brand-name Oxycodone HCI as a morphine-derived painkiller to rival Purdue Pharma’s best-selling brand OxyContin. Purdue has tried to limit production of time-release and generic brands of oxycodone and has been embroiled in several lawsuits to maintain control of its $3 billion-per-year drug. According to its website, Lehigh Valley has developed its own version of abuse-deterrent drugs. In 2009, Lehigh Valley received a warning from the FDA for marketing an unapproved version of morphine, as detailed in this letter from the FDA. Like the brand-name OxyContin, Oxycodone HCI is a Schedule II narcotic and highly prone to addiction.

Read more about Purdue’s suppression of generic forms of oxycodone here.

Posted in Pharmaceutical Industry | Tagged: , , , , , , , , , , , , , , , , , | Leave a Comment »

New drug for Oxy, heroin addiction approved by FDA

Posted by Oxy Watchdog on October 18, 2010

A new treatment for opioid addiction – which includes heroin and painkillers like OxyContin and Vicodin – was approved by the U.S. Food and Drug Administration earlier this week, according to this article in USA Today. Unlike existing treatments which are essentially low-dose versions of the drug, Vivitrol is a once-monthly injection that blocks the effects of opiate drugs and is non-addictive. Though Vivitrol will sell for about $1,100 per injection, the creators are developing an implant that will last for six months, reports this article in the Washington Post. The article also cites a study by the National Institute on Drug Abuse which found that about 810,000 Americans are addicted to heroin and another 1.85 million to opioid painkillers such as OxyContin.

Read about the drug buprenorphine used in opioid addiction treatment here.

Posted in Informational, Pharmaceutical Industry, Policy & Regulation, Trends | Tagged: , , , , , , , , , , , , , | Leave a Comment »

Percocet abuse threatens OxyContin’s hold on teen users

Posted by Oxy Watchdog on October 10, 2010

Though prescription drug abuse has skyrocketed in the past ten years with the painkiller OxyContin as the main drug of choice, teen users may now be switching to a similar prescription opiate, Percocet. According to this article in Wicked Local Bridgewater, Massachusetts police report an increase in Percocet-related crime in the past few months. Possible reasons for the switch include a lower price-tag – Percocet sells for $30 per tablet as compared to the $80 price tag on OxyContin – as well as more availability in the wake of the state’s crackdown on OxyContin. Like Oxy, Percocet contains oxycodone, is a Schedule II narcotic, and is a highly addictive “gateway” drug which may lead to stronger street drugs such as heroin.

Read more about Massachusetts’ battle with Oxy here.

Posted in Crime, Trends | Tagged: , , , , , , , , , , , , , , , , , | Leave a Comment »

New opioid painkiller may rival OxyContin in the marketplace

Posted by Oxy Watchdog on September 30, 2010

As the pharmaceutical companies Grunenthal and Johnson & Johnson release positive final-stage trial results for their new opioid painkiller tapentadol extended-release, market predictors estimate the new drug will rival or possibly even replace OxyContin as the top medication for chronic pain. According to this article in Trading Markets.com, Datamonitor forecasts sales to reach over $800 million by 2019. If approved for sale in the U.S., tapentadol will be the first new opioid to reach the marketplace in over 25 years. As an opioid-based, Schedule II drug like OxyContin, tapentadol may also become highly addictive and should be used under careful supervision, states Johnson & Johnson in this press release.

Posted in Pharmaceutical Industry | Tagged: , , , , , , , , , , , | 1 Comment »

DEA launches first-ever Prescription Drug Take-Back Day

Posted by Oxy Watchdog on September 20, 2010

In response to the nation’s growing prescription drug abuse problem, the Drug Enforcement Administration is sponsoring the first-ever National Prescription Drug Take-Back Day this Saturday, Sept. 25. Government, community, public health and law enforcement partners will be collecting expired, unused, and unwanted prescription drugs for destruction at sites across the nation from 10 a.m. to 2 p.m. local time. The service is free and anonymous, no questions asked.

Watch Joanne Peterson of Learn To Cope weigh in on the event here, and read more about the DEA’s campaign here.

Find a collection site near you here.

Posted in Policy & Regulation | Tagged: , , , , , , , , , , , , , , , , , | 3 Comments »

Doctor fraudulently prescribes painkillers to homeless

Posted by Oxy Watchdog on September 15, 2010

Zhiwei Lin, a California neurologist, was arrested earlier this month for writing prescriptions for Vicodin to those who did not need it. Like OxyContin, Vicodin is a powerful, Schedule II opiate prone to abuse. According to this article in the Los Angeles Times, the homeless “patients” were paid by drug dealers to obtain prescriptions from Lin. The dealers would then sell the painkillers at an increased price. Lin’s ability to prescribe drugs prone to abuse, and even his license, may now be in jeopardy.  The arrest follows the case of another California doctor, Lisa Tseng, who has been linked to six overdose deaths from prescriptions she wrote.

Read about the arrest of Lisa Tseng here.

Posted in Crime | Tagged: , , , , , , | Leave a Comment »

Seattle hospitals ban use of OxyContin

Posted by Oxy Watchdog on September 1, 2010

Two emergency rooms in Seattle, Wash. will no longer prescribe Schedule II narcotics – including OxyContin – to treat pain. Swedish Hospital Cherry Hill’s ER Director Russell Carlisle, Ph.d., told KUOW News that the ban is a form of “tough love” to prevent patients from becoming hooked on the highly addictive pain medications, and also a way to curb existing abuse. Instead, doctors will be prescribing non–narcotic, non-addictive pain medication like acetaminophen or less addictive Schedule III drugs such as codeine. Though Schedule II drugs still have their place in pain treatment, Carlisle says the need for OxyContin and hydrocodone are debatable in an emergency room.

Posted in Policy & Regulation | Tagged: , , , , , , , , , | Leave a Comment »

 
%d bloggers like this: